Open original FDA record ↗Recall record
- FDA identifier
- Z-0686-06
- Company in FDA record
- Kerr Corp
- FDA classification date
- Mar 28, 2006
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The affected lot of product may not activate properly throughout the full intended shelf life and may result in lower than expected bonding performance.
Source facts
- Action
- A total of one hundred thirty five (135) consignees were sent the recall communication via USPS 1st class mail and international fax/mail on March 3 and 6, 2006, respectively. There will be an additional thirty seven (37) letters to be sent to consignees in Australia and three (3) letters to be sent to consignees in New Zealand once the Australian Therapeutic Goods Administration approves of a differently formatted letter. The consignees were instructed to complete the Return Form and return any affected product in their inventory. They were also requested to recover any affected product that they may have shipped to their customers.
- Initiated
- 2006-03-03
- Root cause
- Other
- Terminated
- 2012-03-07
- Distribution
- Nationwide, Australia, Belgium, Canada, Denmark, Germany, Hungary, Italy, Russia, Spain, United Kingdom, & New Zealand.
- Recall number
- Z-0686-06
- Recall status
- Terminated
- CDRH record ID
- 44616
- FDA classified
- 2006-03-28
- Recall event number
- 34769